Gerresheimer (ETR:GXI) Receives “Neutral” Rating from DZ Bank

DZ Bank reiterated their neutral rating on shares of Gerresheimer (ETR:GXI) in a research report sent to investors on Thursday morning, Borsen Zeitung reports.

Other equities research analysts have also issued research reports about the stock. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) target price on shares of Diageo and gave the company a neutral rating in a research note on Wednesday, July 10th. Credit Suisse Group reaffirmed a hold rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Deutsche Bank cut their target price on shares of from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating on the stock in a research note on Monday, June 24th. Kepler Capital Markets set a €19.00 ($22.09) target price on shares of Rhoen Klinikum and gave the company a sell rating in a research note on Thursday, April 11th. Finally, Independent Research set a €72.00 ($83.72) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research note on Friday, April 12th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Gerresheimer has a consensus rating of Hold and a consensus target price of €69.45 ($80.75).

Shares of GXI opened at €73.65 ($85.64) on Thursday. The company’s 50-day moving average is €65.08. The company has a market cap of $2.31 billion and a price-to-earnings ratio of 12.90. The company has a debt-to-equity ratio of 68.19, a current ratio of 0.78 and a quick ratio of 0.51. Gerresheimer has a 1-year low of €51.10 ($59.42) and a 1-year high of €80.25 ($93.31).

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

See Also: Cost of Equity

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.